Videlis Nduba, MD, PhD

Centre Director, Centre for Respiratory Diseases Research (CRDR), Kenya Medical Research Institute (KEMRI)

Dr. Videlis Nduba, MD, PhD, is a centre director at the Centre for Respiratory Diseases Research, Kenya Medical Research Institute, in Nairobi, Kenya. As a medical officer from Kenya and epidemiologist trained at the school of public health at the University of Washington, Seattle, he started his career working in HIV and eventually transitioned to respiratory diseases. He has 18 years of clinical trials experience and has conducted multiple trials in tuberculosis vaccines, TB drug trials, sickle cell disease, and malaria drug trials.

Publications

  1. Papi, A, Greening, NJ, Bhatt, SP, Roche, N, Celli, B, Wedzicha, JA et al.. Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. Lancet. 2026;407 (10543):2027-2039. doi: 10.1016/S0140-6736(26)00637-9. PubMed PMID:42150581 .
  2. Dagnew, AF, Noble, R, Cinar, A, Burhan, E, Churchyard, G, Fairlie, L et al.. Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine. Vaccine. 2026;85 :128690. doi: 10.1016/j.vaccine.2026.128690. PubMed PMID:42119392 .
  3. Musau, S, Odera, S, Onyango, N, Musyoki, VM, Wandiga, S, Nduba, V et al.. Modified cetyltrimethylammonium bromide DNA extraction for Mycobacterium tuberculosis whole genome sequencing. Pan Afr Med J. 2026;53 :28. doi: 10.11604/pamj.2026.53.28.50239. PubMed PMID:42111515 PubMed Central PMC13156016.
  4. Newby, RE, Kijaro, L, Dill-McFarland, KA, Njagi, LN, Murithi, WB, Mwongera, Z et al.. A whole-blood transcriptional signature associated with obstructive post-tuberculosis lung disease. medRxiv. 2026; :. doi: 10.64898/2026.03.11.26348051. PubMed PMID:42051569 PubMed Central PMC13119348.
  5. Mullen, B, Githua, J, Escudero, JN, Mecha, J, Kijaro, L, Ndunge, M et al.. Evaluation of non-sputum-based diagnostics for pediatric tuberculosis: the Pediatric TB Diagnostic (PDTBDx) cohort protocol. medRxiv. 2026; :. doi: 10.64898/2026.04.01.26350011. PubMed PMID:41959800 PubMed Central PMC13060392.
Search PubMed